Imaging, subjective complaints, and MCI: 30 Years before

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The neuropathological and cognitive changes preceding Alzheimer's disease (AD) appear to begin decades before disease symptoms make the clinical diagnosis obvious. Clinical trials have begun to focus on preventive treatments aimed to slow cognitive decline in people with only subjective memory complaints. However, it is not clear how many years before clinical diagnosis of Alzheimer's disease is possible to recognize early signs of neurodegeneration. We report evidence from the literature showing feasibility to diagnose AD at the stage of mild cognitive impairment (MCI) and also a few years before the MCI stage with imaging markers. However, we showed that neuroimaging brain changes evidenced decades before MCI are not early signs of neurodegeneration but expression of genetic risk states for AD or markers of inter-individual variability of cognitive performance due to genetic or environmental factors. The Journal of Nutrition, Health & Aging

Original languageEnglish
JournalJournal of Nutrition, Health and Aging
Volume12
Issue number1
Publication statusPublished - Jan 2008

Fingerprint

Alzheimer disease
Alzheimer Disease
image analysis
cognition
Neuroimaging
signs and symptoms (animals and humans)
clinical trials
Clinical Trials
nutrition
brain
environmental factors
Cognitive Dysfunction
Health
Brain

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Ageing
  • Endocrinology
  • Food Science

Cite this

@article{4d1e1c7374bf48bfba6a4da1c4e40f3e,
title = "Imaging, subjective complaints, and MCI: 30 Years before",
abstract = "The neuropathological and cognitive changes preceding Alzheimer's disease (AD) appear to begin decades before disease symptoms make the clinical diagnosis obvious. Clinical trials have begun to focus on preventive treatments aimed to slow cognitive decline in people with only subjective memory complaints. However, it is not clear how many years before clinical diagnosis of Alzheimer's disease is possible to recognize early signs of neurodegeneration. We report evidence from the literature showing feasibility to diagnose AD at the stage of mild cognitive impairment (MCI) and also a few years before the MCI stage with imaging markers. However, we showed that neuroimaging brain changes evidenced decades before MCI are not early signs of neurodegeneration but expression of genetic risk states for AD or markers of inter-individual variability of cognitive performance due to genetic or environmental factors. The Journal of Nutrition, Health & Aging",
author = "S. Galluzzi and Frisoni, {Giovanni B.}",
year = "2008",
month = "1",
language = "English",
volume = "12",
journal = "Journal of Nutrition, Health and Aging",
issn = "1279-7707",
publisher = "Springer Paris",
number = "1",

}

TY - JOUR

T1 - Imaging, subjective complaints, and MCI

T2 - 30 Years before

AU - Galluzzi, S.

AU - Frisoni, Giovanni B.

PY - 2008/1

Y1 - 2008/1

N2 - The neuropathological and cognitive changes preceding Alzheimer's disease (AD) appear to begin decades before disease symptoms make the clinical diagnosis obvious. Clinical trials have begun to focus on preventive treatments aimed to slow cognitive decline in people with only subjective memory complaints. However, it is not clear how many years before clinical diagnosis of Alzheimer's disease is possible to recognize early signs of neurodegeneration. We report evidence from the literature showing feasibility to diagnose AD at the stage of mild cognitive impairment (MCI) and also a few years before the MCI stage with imaging markers. However, we showed that neuroimaging brain changes evidenced decades before MCI are not early signs of neurodegeneration but expression of genetic risk states for AD or markers of inter-individual variability of cognitive performance due to genetic or environmental factors. The Journal of Nutrition, Health & Aging

AB - The neuropathological and cognitive changes preceding Alzheimer's disease (AD) appear to begin decades before disease symptoms make the clinical diagnosis obvious. Clinical trials have begun to focus on preventive treatments aimed to slow cognitive decline in people with only subjective memory complaints. However, it is not clear how many years before clinical diagnosis of Alzheimer's disease is possible to recognize early signs of neurodegeneration. We report evidence from the literature showing feasibility to diagnose AD at the stage of mild cognitive impairment (MCI) and also a few years before the MCI stage with imaging markers. However, we showed that neuroimaging brain changes evidenced decades before MCI are not early signs of neurodegeneration but expression of genetic risk states for AD or markers of inter-individual variability of cognitive performance due to genetic or environmental factors. The Journal of Nutrition, Health & Aging

UR - http://www.scopus.com/inward/record.url?scp=38549085186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549085186&partnerID=8YFLogxK

M3 - Article

C2 - 18165851

AN - SCOPUS:38549085186

VL - 12

JO - Journal of Nutrition, Health and Aging

JF - Journal of Nutrition, Health and Aging

SN - 1279-7707

IS - 1

ER -